These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 27842504)

  • 1. EpCAM as multi-tumour target for near-infrared fluorescence guided surgery.
    van Driel PB; Boonstra MC; Prevoo HA; van de Giessen M; Snoeks TJ; Tummers QR; Keereweer S; Cordfunke RA; Fish A; van Eendenburg JD; Lelieveldt BP; Dijkstra J; van de Velde CJ; Kuppen PJ; Vahrmeijer AL; Löwik CW; Sier CF
    BMC Cancer; 2016 Nov; 16(1):884. PubMed ID: 27842504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation.
    Boogerd LSF; Boonstra MC; Prevoo HAJM; Handgraaf HJM; Kuppen PJK; van de Velde CJH; Fish A; Cordfunke RA; Valentijn ARPM; Terwisscha van Scheltinga AG; MacDonald GC; Cizeau J; Premsukh A; Vinkenburg van Slooten ML; Burggraaf J; Sier CFM; Vahrmeijer AL
    Surg Oncol; 2019 Mar; 28():1-8. PubMed ID: 30851880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer.
    Houvast RD; Badr N; March T; de Muynck LDAN; Sier VQ; Schomann T; Bhairosingh S; Baart VM; Peeters JAHM; van Westen GJP; Plückthun A; Burggraaf J; Kuppen PJK; Vahrmeijer AL; Sier CFM
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2179-2192. PubMed ID: 37642704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.
    Hall MA; Pinkston KL; Wilganowski N; Robinson H; Ghosh P; Azhdarinia A; Vazquez-Arreguin K; Kolonin AM; Harvey BR; Sevick-Muraca EM
    J Nucl Med; 2012 Sep; 53(9):1427-37. PubMed ID: 22872743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma.
    Baart VM; van der Horst G; Deken MM; Bhairosingh SS; Schomann T; Sier VQ; van der Mark MH; Iamele L; de Jonge H; Resnati M; Mazar AP; Pelger RCM; van der Pluijm G; Kuppen PJK; Vahrmeijer AL; Sier CFM
    Eur J Cancer; 2021 Mar; 146():11-20. PubMed ID: 33561783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.
    Boonstra MC; Tolner B; Schaafsma BE; Boogerd LS; Prevoo HA; Bhavsar G; Kuppen PJ; Sier CF; Bonsing BA; Frangioni JV; van de Velde CJ; Chester KA; Vahrmeijer AL
    Int J Cancer; 2015 Oct; 137(8):1910-20. PubMed ID: 25895046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of near-infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence-guided surgery.
    Saccomano M; Dullin C; Alves F; Napp J
    Int J Cancer; 2016 Nov; 139(10):2277-89. PubMed ID: 27428782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a novel ovarian cancer-specific fluorescent antibody probe for targeted near-infrared fluorescence imaging.
    Chen J; Zhang C; Guo Y; Chang X; Ma R; Ye X; Cheng H; Li Y; Cui H
    World J Surg Oncol; 2020 Apr; 18(1):66. PubMed ID: 32252772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
    Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
    Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycan-Based Near-infrared Fluorescent (NIRF) Imaging of Gastrointestinal Tumors: a Preclinical Proof-of-Concept In Vivo Study.
    Houvast RD; Baart VM; Bhairosingh SS; Cordfunke RA; Chua JX; Vankemmelbeke M; Parsons T; Kuppen PJK; Durrant LG; Vahrmeijer AL; Sier CFM
    Mol Imaging Biol; 2020 Dec; 22(6):1511-1522. PubMed ID: 32780212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP.
    Zhu B; Wu G; Robinson H; Wilganowski N; Hall MA; Ghosh SC; Pinkston KL; Azhdarinia A; Harvey BR; Sevick-Muraca EM
    Mol Imaging Biol; 2013 Oct; 15(5):560-8. PubMed ID: 23619897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo.
    Ni J; Cozzi P; Beretov J; Duan W; Bucci J; Graham P; Li Y
    BMC Cancer; 2018 Nov; 18(1):1092. PubMed ID: 30419852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
    Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
    Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery.
    Boonstra MC; van Driel PB; van Willigen DM; Stammes MA; Prevoo HA; Tummers QR; Mazar AP; Beekman FJ; Kuppen PJ; van de Velde CJ; Löwik CW; Frangioni JV; van Leeuwen FW; Sier CF; Vahrmeijer AL
    Oncotarget; 2015 Jun; 6(16):14260-73. PubMed ID: 25895028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer.
    Lütje S; Rijpkema M; Goldenberg DM; van Rij CM; Sharkey RM; McBride WJ; Franssen GM; Frielink C; Helfrich W; Oyen WJ; Boerman OC
    Cancer Res; 2014 Nov; 74(21):6216-23. PubMed ID: 25252911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-modal imaging probe for EpCAM overexpressed in breast cancer.
    Dai Y; Tang Y; Huang W; Zhao Y; Gao X; Gu Y
    Talanta; 2022 Dec; 250():123715. PubMed ID: 35868149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models.
    Zhang M; Kobayashi N; Zettlitz KA; Kono EA; Yamashiro JM; Tsai WK; Jiang ZK; Tran CP; Wang C; Guan J; Wu AM; Reiter RE
    Clin Cancer Res; 2019 Jan; 25(1):188-200. PubMed ID: 30301826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors.
    Baart VM; van Manen L; Bhairosingh SS; Vuijk FA; Iamele L; de Jonge H; Scotti C; Resnati M; Cordfunke RA; Kuppen PJK; Mazar AP; Burggraaf J; Vahrmeijer AL; Sier CFM
    Mol Imaging Biol; 2023 Feb; 25(1):122-132. PubMed ID: 34642899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIR-II fluorescence imaging-guided colorectal cancer surgery targeting CEACAM5 by a nanobody.
    Guo X; Li C; Jia X; Qu Y; Li M; Cao C; Zhang Z; Qu Q; Luo S; Tang J; Liu H; Hu Z; Tian J
    EBioMedicine; 2023 Mar; 89():104476. PubMed ID: 36801616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.
    Gutowski M; Framery B; Boonstra MC; Garambois V; Quenet F; Dumas K; Scherninski F; Cailler F; Vahrmeijer AL; Pèlegrin A
    Surg Oncol; 2017 Jun; 26(2):153-162. PubMed ID: 28577721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.